Vitamin D for COVID-19
8th treatment shown to reduce risk in
October 2020, now with p < 0.0000000001 from 138 studies, recognized in 18 countries.
No treatment is 100% effective.
Protocols combine treatments.
Review of the effects of COVID-19 on inflammatory markers, and the effects on those markers of standard treatments vs. vitamin D, melatonin, and meditation, showing comparable or superior effects with the non-standard treatments. The standard treatments in this study were remdesivir and tocilizumab. We note that standard treatments vary widely around the world, for example vitamin D is a standard treatment in many locations.
Study covers melatonin and vitamin D.
1.
Younes, S., The influence of micronutrients on olfactory dysfunction associated with COVID-19 and long COVID, Next Research, doi:10.1016/j.nexres.2026.101727.
2.
Jaurrieta-Largo et al., A Machine Learning Approach to Understanding the Genetic Role in COVID-19 Prognosis: The Influence of Gene Polymorphisms Related to Inflammation, Vitamin D, and ACE2, International Journal of Molecular Sciences, doi:10.3390/ijms26167975.
3.
Al-Khrasani et al., Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2025.118346.
4.
Kow et al., Vitamin D and COVID‐19: How much more evidence do we need?, Nutrition in Clinical Practice, doi:10.1002/ncp.11349.
5.
Bigman et al., A Comprehensive Scoping Review on Diet and Nutrition in Relation to Long COVID-19 Symptoms and Recovery, Nutrients, doi:10.3390/nu17111802.
6.
Hewison, M., COVID-19 and our understanding of vitamin D and immune function, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2025.106710.
7.
Wimalawansa, S., Vitamin D Deficiency Meets Hill’s Criteria for Causation in SARS-CoV-2 Susceptibility, Complications, and Mortality: A Systematic Review, Nutrients, doi:10.3390/nu17030599.
8.
Sanduzzi Zamparelli et al., Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective, Life, doi:10.3390/life15010113.
9.
Fazli et al., Possible Link between Gut Microbiota, Diet, and COVID-19 Infection, Journal of Medical Bacteriology, 12:4, jmb.tums.ac.ir/index.php/jmb/article/view/525.
10.
Wojciulik et al., The impact of genetic polymorphism on course and severity of the SARS-CoV-2 infection and COVID-19 disease, Przeglad Epidemiologiczny, doi:10.32394/pe/194862.
11.
Wimalawansa (B), S., Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2, Biology, doi:10.3390/biology13100831.
12.
Santa et al., Comparative analysis of COVID-19 responses in Japan and Africa: diet, phytochemicals, vitamin D, and gut microbiota in reducing mortality—A systematic review and meta-analysis, Frontiers in Nutrition, doi:10.3389/fnut.2024.1465324.
13.
Kaushal, A., Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections, Journal of Translational Medicine, doi:10.1186/s12967-024-05587-9.
14.
Mu et al., Anti-inflammatory and Nutritional Interventions Against SARS-CoV-2: A Comprehensive Review, Journal of Agriculture and Food Research, doi:10.1016/j.jafr.2024.101422.
15.
Wimalawansa (C), S., Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future Pandemic Resilience Strategies with Strengthening Natural Immunity, Heliyon, doi:10.1016/j.heliyon.2024.e34691.
16.
Imran et al., Therapeutic Role of Vitamin D in COVID-19 Patients, Clinical Nutrition Open Science, doi:10.1016/j.nutos.2024.07.004.
17.
Grant, W., Vitamin D and viral infections: Infectious diseases, autoimmune diseases, and cancers, Advances in Food and Nutrition Research, doi:10.1016/bs.afnr.2023.12.007.
18.
Polonowita et al., Molecular Quantum and Logic Process of Consciousness—Vitamin D Big-Data in COVID-19—A Case for Incorporating Machine Learning In Medicine, European Journal of Biomedical and Pharmaceutical sciences, doi:10.5281/zenodo.10435649.
19.
Gomaa et al., Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy, Inflammopharmacology, doi:10.1007/s10787-023-01383-x.
20.
Gotelli et al., Understanding the immune-endocrine effects of vitamin D in SARS-CoV-2 infection: a role in protecting against neurodamage?, Neuroimmunomodulation, doi:10.1159/000533286.
21.
Cutolo et al., Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19, Nature Reviews Rheumatology, doi:10.1038/s41584-023-00944-2.
22.
Schloss et al., Nutritional deficiencies that may predispose to long COVID, Inflammopharmacology, doi:10.1007/s10787-023-01183-3.
23.
Arora et al., Global Dietary and Herbal Supplement Use during COVID-19—A Scoping Review, Nutrients, doi:10.3390/nu15030771.
24.
Nicoll et al., COVID-19 Prevention: Vitamin D Is Still a Valid Remedy, Journal of Clinical Medicine, doi:10.3390/jcm11226818.
25.
Foshati et al., Antioxidants and clinical outcomes of patients with coronavirus disease 2019: A systematic review of observational and interventional studies, Food Science & Nutrition, doi:10.1002/fsn3.3034.
26.
Quesada-Gomez et al., Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol, Nutrients, doi:10.3390/nu14132716.
27.
DiGuilio et al., Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy, International Journal of Molecular Sciences, doi:10.3390/ijms23062995.
28.
Grant (B) et al., A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health, Nutrients, doi:10.3390/nu14030639.
29.
Shaw Stewart et al., Temperature dependent viral tropism: understanding viral seasonality and pathogenicity as applied to the avoidance and treatment of endemic viral respiratory illnesses, Reviews in Medical Virology, doi:10.1002/rmv.2241.
30.
Shah Alam et al., The role of vitamin D in reducing SARS-CoV-2 infection: An update, International Immunopharmacology, doi:10.1016/j.intimp.2021.107686.
31.
Griffin et al., Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19, Clinical Medicine, doi:10.7861/clinmed.2021-0035.
32.
Kohlmeier et al., When Mendelian randomisation fails, BMJ Nutrition, Prevention & Health, doi:10.1136/bmjnph-2021-000265.
33.
Brenner, H., Vitamin D Supplementation to Prevent COVID-19 Infections and Deaths—Accumulating Evidence from Epidemiological and Intervention Studies Calls for Immediate Action, Nutrients, doi:10.3390/nu13020411.
34.
Mercola et al., Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity, Nutrients 2020, 12:11, 3361, doi:10.3390/nu12113361.
35.
Basha et al., Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling, Clinical Epidemiology and Global Health, doi:10.1016/j.cegh.2020.10.005.
36.
Xu et al., The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19, Journal of Translational Medicine, doi:10.1186/s12967-020-02488-5.
37.
Alexander et al., Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19, Nutrients, doi:10.3390/nu12082358.
38.
Andrade et al., Vitamin A and D deficiencies in the prognosis of respiratory tract infections: A systematic review with perspectives for COVID-19 and a critical analysis on supplementation, SciELO preprints, doi:10.1590/SciELOPreprints.839.
39.
Grant (C) et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, 12:4, 988, doi:10.3390/nu12040988.
40.
McCullough et al., Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience, The Journal of Steroid Biochemistry and Molecular Biology, doi:10.1016/j.jsbmb.2018.12.010.
41.
EFSA, Scientific Opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (E, EFSA Journal, doi:10.2903/j.efsa.2010.1468.
42.
EFSA (B), Scientific Opinion on the substantiation of a health claim related to vitamin D and contribution to the normal function of the immune system pursuant to Article 14 of Regulation (EC) No 1924/2006, EFSA Journal, doi:10.2903/j.efsa.2015.4096.
Castle et al., 22 Sep 2021, peer-reviewed, 8 authors.
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation
Journal of Inflammation Research, doi:10.2147/jir.s323356
Introduction: COVID-19 poses a chronic threat to inflammatory systems, reinforcing the need for efficient anti-inflammatory strategies. The purpose of this review and analysis was to determine the efficacy of various interventions upon the inflammatory markers most affected by COVID-19. The focus was on the markers associated with COVID-19, not the etiology of the virus itself. Methods: Based on 27 reviewed papers, information was extracted on the effects of COVID-19 upon inflammatory markers, then the effects of standard treatments (Remdesivir, Tocilizumab) and adjunctive interventions (vitamin D 3 , melatonin, and meditation) were extracted for those markers. These data were used to approximate effect sizes for the disease or interventions via standardized mean differences (SMD). Results: The data that were available indicated that adjunctive interventions affected 68.4% of the inflammatory markers impacted by COVID-19, while standard pharmaceutical medication affected 26.3%. Discussion: Nonstandard adjunctive care appeared to have comparable or superior effects in comparison to Remdesivir and Tocilizumab on the inflammatory markers most impacted by COVID-19. Alongside standards of care, melatonin, vitamin D 3 , and meditation should be considered for treatment of SARS-COV-2 infection and COVID-19 disease.
Disclosure The authors report no conflicts of interest for this work.
Video abstract Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: https://youtu.be/2i2QG5lT0JI
Journal of Inflammation Research
Dovepress
References
Aiswarya, Arumugam, Dineshkumar, Use of remdesivir in patients with COVID-19 on hemodialysis: a Study of Safety and Tolerance, Kidney Int Rep, doi:10.1016/j.ekir.2020.12.003
Akbari, Tabrizi, Lankarani, The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis, Life Sci, doi:10.1016/j.lfs.2020.118167
Alamdari, Mahdavi, Roshanravan, Placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women, Horm Metab Res, doi:10.1055/s-0034-1384587
Ali, Katz, Disease prevention and health promotion, Am J Prev Med, doi:10.1016/j.amepre.2015.07.019
Amiri-Dashatan, Koushki, Ghorbani, Naderi, Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis, Gastroenterol Hepatol Bed Bench
Bartels, Jørgensen, Bendix, 25-hydroxy vitamin D3 modulates dendritic cell phenotype and function in crohn's disease, Inflammopharmacology, doi:10.1007/s10787-012-0168-y
Black, Stress and the inflammatory response: a review of neurogenic inflammation, Brain Behav Immun, doi:10.1016/s0889-1591(02)00021-1
Bower, Crosswell, Stanton, Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial, Cancer, doi:10.1002/cncr.29194
Bushell, Castle, Williams, Meditation and yoga practices as potential adjunctive treatment of SARS-CoV-2 infection and COVID-19: a brief overview of key subjects, Journal of Inflammation Research, doi:10.1089/acm.2020.0177
Bushell, Theise, Toward a unified field of study: longevity, regeneration, and protection of health through meditation and related practices, Ann N Y Acad Sci, doi:10.1111/j.1749-6632.2009.04959.x
Ca, Kip, Post-White, Lymphocyte recovery after breast cancer treatment and mindfulness-based stress reduction (MBSR) therapy, Biol Res Nurs, doi:10.1177/1099800411419245
Cahn, Goodman, Peterson, Maturi, Mills, Yoga, meditation and mind-body health: increased BDNF, cortisol awakening response, and altered inflammatory marker expression after a 3-month yoga and meditation retreat, Front Hum Neurosci, doi:10.3389/fnhum.2017.00315
Carlson, Speca, Faris, Patel, One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients, Brain Behav Immun, doi:10.1016/j.bbi.2007.04.002
Carlson, Speca, Patel, Goodey, Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients, Psychoneuroendocrinology, doi:10.1016/s0306-4530(03)00054-4
Carlson, Speca, Patel, Goodey, Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients, Psychosom Med, doi:10.1097/01.psy.0000074003.35911.41
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105751
Celinski, Konturek, Slomka, Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease-14 months follow up, J Physiol Pharmacol
Chen, Liu, Liu, Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia, Zhonghua Jie He He Hu Xi Za Zhi, doi:10.3760/cma.j.issn.1001-0939.2020.0005
Chen, Wu, Guo, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, doi:10.1172/JCI137244
Chen, Zheng, Yu, Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage, EMBO J, doi:10.15252/embj.2020105896
Choudhary, Sharma, Silakari, The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options, Microb Pathog, doi:10.1016/j.micpath.2020.104673
Cichoz-Lach, Celinski, Konturek, Konturek, Slomka, The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis, J Physiol Pharmacol
Conti, Ronconi, Caraffa, Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies, J Biol Regul Homeost Agents, doi:10.23812/CONTI-E
Epel, Puterman, Lin, Meditation and vacation effects have an impact on disease-associated molecular phenotypes, Transl Psychiatry, doi:10.1038/tp.2016.164
Faraone, Interpreting estimates of treatment effects, P T
Feitosa, Júnior, Neto, COVID-19: rational discovery of the therapeutic potential of melatonin as a SARS-CoV-2 main protease inhibitor, Int J Med Sci, doi:10.7150/ijms.48053
Gonzalez-Garcia, Ferrer, Borras, Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection, AIDS Behav, doi:10.1007/s10461-013-0612-z
Grant, Lahore, Mcdonnell, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients, doi:10.3390/nu12040988
Gustine, Jones, Immunopathology of hyperinflammation in COVID-19, Am J Pathol, doi:10.1016/j.ajpath.2020.08.009
Hu, Huang, Alleviation of inflammatory response of pulmonary fibrosis in acute respiratory distress syndrome by puerarin via Transforming Growth Factor (TGF-beta1), Med Sci Monit, doi:10.12659/MSM.915570
Hunter, The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment, EMBO Rep, doi:10.1038/embor.2012.142
Isik, Ozuguz, Tutuncu, Serum transforming growth factor-beta levels in patients with vitamin D deficiency, Eur J Intern Med, doi:10.1016/j.ejim.2011.09.017
Javanmard, Heshmat-Ghahdarijani, Mirmohammad-Sadeghi, Sonbolestan, Ziayi, The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery, Adv Biomed Res, doi:10.4103/2277-9175.194801
Jolliffe, Camargo, Sluyter, Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol, doi:10.1016/S2213-8587(21)00051-6
Kapepula, Kabengele, Kingombe, Artemisia Spp. derivatives for COVID-19 treatment: anecdotal use, political hype, treatment potential, challenges, and road map to randomized clinical trials, Am J Trop Med Hyg, doi:10.4269/ajtmh.20-0820
Leijte, Wagemaker, Van Kraaij, Mortality and re-admission after hospitalization with COVID-19, Ned Tijdschr Geneeskd
Li, Wang, Jou, SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-beta1 via ROS/p38 MAPK/STAT3 pathway, Sci Rep, doi:10.1038/srep25754
Li, Zhang, Guan, SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation, Signal Transduct Target Ther, doi:10.1038/s41392-020-00334-0
Libby, Inflammatory mechanisms: the molecular basis of inflammation and disease, Nutr Rev, doi:10.1111/j.1753-4887.2007.tb00352.x
Lin, Wu, Xie, Clinical study of artesunate in the treatment of coronavirus disease, doi:10.3760/cma.j.cn121430-20200312-00412
Ling, Broad, Murphy, High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a Cross-Sectional Multi-Centre Observational Study, Nutrients, doi:10.3390/nu12123799
Magro, SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides tocilizumab? SGP130Fc, Cytokine X, doi:10.1016/j.cytox.2020.100029
Mak, Ho, Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease, Respir Med, doi:10.1016/j.rmed.2009.01.005
Mcdonald, Healing after COVID-19: are survivors at risk for pulmonary fibrosis?, Am J Physiol Lung Cell Mol Physiol, doi:10.1152/ajplung.00238.2020
Mendelson, Nel, Blumberg, Long-COVID: an evolving problem with an extensive impact, S Afr Med J, doi:10.7196/SAMJ.2020.v111i11.15433
Meng, Xiao, Zhang, Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension, Emerg Microbes Infect, doi:10.1080/22221751.2020.1746200
Mihara M 1, Kasutani, Okazaki, Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family, Int Immunopharmacol, doi:10.1016/j.intimp.2005.05.010
Morgan, Irwin, Chung, Wang, Bacurau, The effects of mind-body therapies on the immune system: meta-analysis, PLoS One, doi:10.1371/journal.pone.0100903
Mu, Ding, Li, Chen, Ma, Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-beta/Smad signaling pathway, Thromb Res, doi:10.1016/j.thromres.2011.10.003
O'sullivan, Long-term sequelae following previous coronavirus epidemics, Clin Med, doi:10.7861/clinmed.2020-0204
Panigrahy, Gilligan, Huang, Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?, Cancer Metastasis Rev, doi:10.1007/s10555-020-09889-4
Pittet, Griffiths, Geiser, TGF-beta is a critical mediator of acute lung injury, J Clin Invest, doi:10.1172/JCI11963
Pollard, Morran, Al, The COVID-19 pandemic: a global health crisis, Physiol Genomics, doi:10.1152/physiolgenomics.00089.2020
Pum, Ennemoser, Adage, Kungl, Cytokines and chemokines in SARS-CoV-2 infections-therapeutic strategies targeting cytokine storm, Biomolecules, doi:10.3390/biom11010091
Qin, Zhou, Hu, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis, doi:10.1093/cid/ciaa248
Ramezani, Simani, Karimialavijeh, Rezaei, Hajiesmaeili et al., The role of anxiety and cortisol in outcomes of patients with covid-19, Basic Clin Neurosci, doi:10.32598/bcn.11.covid19.1168.2
Rausch-Fan, Leutmezer, Willheim, Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3, Int Arch Allergy Immunol, doi:10.1159/000058001
Raygan, Ostadmohammadi, Bahmani, Reiter, Asemi, Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial, Clin Nutr, doi:10.1016/j.clnu.2017.12.004
Rea, Gibson, Mcgilligan, Mcnerlan, Alexander et al., Age and age-related diseases: role of inflammation triggers and cytokines, Front Immunol, doi:10.3389/fimmu.2018.00586
Renu, Prasanna, Valsala Gopalakrishnan, Coronaviruses pathogenesis, comorbidities and multi-organ damage -A review, Life Sci, doi:10.1016/j.lfs.2020.117839
Rosenkranz, Lutz, Perlman, Reduced stress and inflammatory responsiveness in experienced meditators compared to a matched healthy control group, Psychoneuroendocrinology, doi:10.1016/j.psyneuen.2016.02.013
Saklayen, The global epidemic of the metabolic syndrome, Curr Hypertens Rep, doi:10.1007/s11906-018-0812-z
Shakoor, Feehan, Dhaheri, Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: could they help against COVID-19?, Maturitas, doi:10.1016/j.maturitas.2020.08.003
Sheppard, Laskou, Stapleton, Hadavi, Dasgupta, Tocilizumab (Actemra), Hum Vaccin Immunother, doi:10.1080/21645515.2017.1316909
Shete, Verma, Kulkarni, Bhogal, Effect of yoga training on inflammatory cytokines and C-reactive protein in employees of small-scale industries, J Educ Health Promot, doi:10.4103/jehp.jehp_65_17
Singh, Gillies, Singh, Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis, Diabetes Obes Metab, doi:10.1111/dom.14124
Smolen, Beaulieu, Rubbert-Roth, Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial, Lancet, doi:10.1016/S0140-6736(08)60453-5
Uckun, Saund, Windlass, Trieu, Repurposing anti-malaria phytomedicine artemisinin as a COVID-19 drug, Front Pharmacol, doi:10.3389/fphar.2021.649532
Verkhratsky, Li, Melino, Melino, Shi, Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?, Biol Direct, doi:10.1186/s13062-020-00282-3
Wang, Kream, Stefano, Long-term respiratory and neurological sequelae of COVID-19, Med Sci Monit, doi:10.12659/MSM.928996
Wang, Lu, Li, SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-beta1 signaling, Virus Res, doi:10.1016/j.virusres.2017.04.008
Wang, Nie, Wang, Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia, J Infect Dis, doi:10.1093/infdis/jiaa150
Wang, Zhang, Du, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, doi:10.1016/S0140-6736(20)31022-9
Wasserstein, Lazar, The ASA statement on p-values: context, process, and purpose, Am Stat, doi:10.1080/00031305.2016.1154108
Witek-Janusek, Albuquerque, Chroniak, Chroniak, Durazo-Arvizu et al., Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer, Brain Behav Immun, doi:10.1016/j.bbi.2008.01.012
Woods, Tazi, Chesarino, Amer, Davis, TGF-betainduced IL-6 prevents development of acute lung injury in influenza A virus-infected F508del CFTR-heterozygous mice, Am J Physiol Lung Cell Mol Physiol, doi:10.1152/ajplung.00078.2015
Xiong, Liu, Cao, Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg Microbes Infect, doi:10.1080/22221751.2020.1747363
Zabetakis, Lordan, Norton, Tsoupras, COVID-19: the inflammation link and the role of nutrition in potential mitigation, Nutrients, doi:10.3390/nu12051466
Zerr, Vollath, Palumbo-Zerr, Vitamin D receptor regulates TGF-beta signalling in systemic sclerosis, Ann Rheum Dis, doi:10.1136/annrheumdis-2013-204378
Zhang, Wang, Ni, COVID-19: melatonin as a potential adjuvant treatment, Life Sci, doi:10.1016/j.lfs.2020.117583
DOI record:
{
"DOI": "10.2147/jir.s323356",
"ISSN": [
"1178-7031"
],
"URL": "http://dx.doi.org/10.2147/JIR.S323356",
"author": [
{
"ORCID": "http://orcid.org/0000-0002-7781-7612",
"affiliation": [],
"authenticated-orcid": true,
"family": "Castle",
"given": "Ryan D",
"sequence": "first"
},
{
"affiliation": [],
"family": "Williams",
"given": "Michelle A",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bushell",
"given": "William C",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Rindfleisch",
"given": "J Adam",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Peterson",
"given": "Christine Tara",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0003-1159-6789",
"affiliation": [],
"authenticated-orcid": true,
"family": "Marzolf",
"given": "James",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Brouwer",
"given": "Kimberly",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mills",
"given": "Paul J",
"sequence": "additional"
}
],
"container-title": "Journal of Inflammation Research",
"container-title-short": "JIR",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
9,
22
]
],
"date-time": "2021-09-22T01:38:50Z",
"timestamp": 1632274730000
},
"deposited": {
"date-parts": [
[
2021,
9,
22
]
],
"date-time": "2021-09-22T01:39:06Z",
"timestamp": 1632274746000
},
"indexed": {
"date-parts": [
[
2023,
4,
21
]
],
"date-time": "2023-04-21T22:49:54Z",
"timestamp": 1682117394412
},
"is-referenced-by-count": 9,
"issued": {
"date-parts": [
[
2021,
9
]
]
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by-nc/3.0/",
"content-version": "unspecified",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
9,
1
]
],
"date-time": "2021-09-01T00:00:00Z",
"timestamp": 1630454400000
}
}
],
"link": [
{
"URL": "https://www.dovepress.com/getfile.php?fileID=73918",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.dovepress.com/getfile.php?fileID=73918",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "301",
"original-title": [],
"page": "4859-4876",
"prefix": "10.2147",
"published": {
"date-parts": [
[
2021,
9
]
]
},
"published-online": {
"date-parts": [
[
2021,
9
]
]
},
"publisher": "Informa UK Limited",
"reference": [
{
"DOI": "10.1152/physiolgenomics.00089.2020",
"author": "Pollard",
"doi-asserted-by": "publisher",
"first-page": "549",
"journal-title": "Physiol Genomics",
"key": "ref1",
"volume": "52",
"year": "2020"
},
{
"DOI": "10.1111/dom.14124",
"author": "Singh",
"doi-asserted-by": "publisher",
"first-page": "1915",
"journal-title": "Diabetes Obes Metab",
"key": "ref2",
"volume": "22",
"year": "2020"
},
{
"DOI": "10.1016/j.ajpath.2020.08.009",
"author": "Gustine",
"doi-asserted-by": "publisher",
"first-page": "4",
"journal-title": "Am J Pathol",
"key": "ref3",
"volume": "191",
"year": "2021"
},
{
"DOI": "10.1007/s10555-020-09889-4",
"author": "Panigrahy",
"doi-asserted-by": "publisher",
"first-page": "337",
"journal-title": "Cancer Metastasis Rev",
"key": "ref4",
"volume": "39",
"year": "2020"
},
{
"DOI": "10.3390/nu12051466",
"author": "Zabetakis",
"doi-asserted-by": "publisher",
"first-page": "5",
"journal-title": "Nutrients",
"key": "ref5",
"volume": "12",
"year": "2020"
},
{
"DOI": "10.1016/j.maturitas.2020.08.003",
"author": "Shakoor",
"doi-asserted-by": "publisher",
"first-page": "1",
"journal-title": "Maturitas",
"key": "ref6",
"volume": "143",
"year": "2021"
},
{
"DOI": "10.1038/embor.2012.142",
"author": "Hunter",
"doi-asserted-by": "publisher",
"first-page": "968",
"journal-title": "EMBO Rep",
"key": "ref7",
"volume": "13",
"year": "2012"
},
{
"DOI": "10.3389/fimmu.2018.00586",
"author": "Rea",
"doi-asserted-by": "publisher",
"first-page": "586",
"journal-title": "Front Immunol",
"key": "ref8",
"volume": "9",
"year": "2018"
},
{
"DOI": "10.1111/j.1753-4887.2007.tb00352.x",
"author": "Libby",
"doi-asserted-by": "publisher",
"first-page": "S140",
"journal-title": "Nutr Rev",
"key": "ref9",
"volume": "65",
"year": "2007"
},
{
"DOI": "10.23812/CONTI-E",
"author": "Conti",
"doi-asserted-by": "publisher",
"first-page": "2",
"journal-title": "J Biol Regul Homeost Agents",
"key": "ref10",
"volume": "34",
"year": "2020"
},
{
"author": "Amiri-Dashatan",
"first-page": "282",
"journal-title": "Gastroenterol Hepatol Bed Bench",
"key": "ref11",
"volume": "13",
"year": "2020"
},
{
"DOI": "10.1016/j.lfs.2020.117839",
"author": "Renu",
"doi-asserted-by": "publisher",
"first-page": "117839",
"journal-title": "Life Sci",
"key": "ref12",
"volume": "255",
"year": "2020"
},
{
"DOI": "10.1016/s0889-1591(02)00021-1",
"author": "Black",
"doi-asserted-by": "publisher",
"first-page": "622",
"journal-title": "Brain Behav Immun",
"key": "ref13",
"volume": "16",
"year": "2002"
},
{
"key": "ref14",
"unstructured": "Coronavirus Disease (COVID-19) situation reports. Avaiable from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed January 28, 2021."
},
{
"DOI": "10.12659/MSM.928996",
"author": "Wang",
"doi-asserted-by": "publisher",
"first-page": "e928996",
"journal-title": "Med Sci Monit",
"key": "ref15",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1186/s13062-020-00282-3",
"author": "Verkhratsky",
"doi-asserted-by": "publisher",
"first-page": "28",
"journal-title": "Biol Direct",
"key": "ref16",
"volume": "15",
"year": "2020"
},
{
"DOI": "10.1152/ajplung.00238.2020",
"author": "McDonald",
"doi-asserted-by": "publisher",
"first-page": "L257",
"journal-title": "Am J Physiol Lung Cell Mol Physiol",
"key": "ref17",
"volume": "320",
"year": "2021"
},
{
"DOI": "10.7861/clinmed.2020-0204",
"author": "O’Sullivan",
"doi-asserted-by": "publisher",
"first-page": "e68",
"journal-title": "Clin Med",
"key": "ref18",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1007/s11906-018-0812-z",
"author": "Saklayen",
"doi-asserted-by": "publisher",
"first-page": "2",
"journal-title": "Curr Hypertens Rep",
"key": "ref19",
"volume": "20",
"year": "2018"
},
{
"author": "Leijte",
"first-page": "D5423",
"journal-title": "Ned Tijdschr Geneeskd",
"key": "ref20",
"volume": "164",
"year": "2020"
},
{
"key": "ref21",
"unstructured": "NIH launches new initiative to study. “Long COVID.” National Institutes of Health (NIH); February 23, 2021. Available from: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid. Accessed March 30, 2021."
},
{
"DOI": "10.1038/s41392-020-00334-0",
"author": "Li",
"doi-asserted-by": "publisher",
"first-page": "235",
"journal-title": "Signal Transduct Target Ther",
"key": "ref22",
"volume": "5",
"year": "2020"
},
{
"DOI": "10.3390/biom11010091",
"author": "Pum",
"doi-asserted-by": "publisher",
"first-page": "1",
"journal-title": "Biomolecules",
"key": "ref23",
"volume": "11",
"year": "2021"
},
{
"DOI": "10.1016/j.micpath.2020.104673",
"author": "Choudhary",
"doi-asserted-by": "publisher",
"first-page": "104673",
"journal-title": "Microb Pathog",
"key": "ref24",
"volume": "150",
"year": "2021"
},
{
"DOI": "10.15252/embj.2020105896",
"author": "Chen",
"doi-asserted-by": "publisher",
"first-page": "e105896",
"journal-title": "EMBO J",
"key": "ref25",
"volume": "39",
"year": "2020"
},
{
"DOI": "10.1016/j.rmed.2009.01.005",
"author": "Mak",
"doi-asserted-by": "publisher",
"first-page": "1083",
"journal-title": "Respir Med",
"key": "ref26",
"volume": "103",
"year": "2009"
},
{
"DOI": "10.1080/22221751.2020.1747363",
"author": "Xiong",
"doi-asserted-by": "publisher",
"first-page": "761",
"journal-title": "Emerg Microbes Infect",
"key": "ref27",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.1152/ajplung.00078.2015",
"author": "Woods",
"doi-asserted-by": "publisher",
"first-page": "L1136",
"journal-title": "Am J Physiol Lung Cell Mol Physiol",
"key": "ref28",
"volume": "308",
"year": "2015"
},
{
"DOI": "10.1016/j.thromres.2011.10.003",
"author": "Mu",
"doi-asserted-by": "publisher",
"first-page": "479",
"journal-title": "Thromb Res",
"key": "ref29",
"volume": "129",
"year": "2012"
},
{
"DOI": "10.1172/JCI11963",
"author": "Pittet",
"doi-asserted-by": "publisher",
"first-page": "1537",
"journal-title": "J Clin Invest",
"key": "ref30",
"volume": "107",
"year": "2001"
},
{
"DOI": "10.7150/ijbs.46891",
"author": "Chen",
"doi-asserted-by": "publisher",
"first-page": "1954",
"journal-title": "Int J Biol Sci",
"key": "ref31",
"volume": "16",
"year": "2020"
},
{
"DOI": "10.12659/MSM.915570",
"author": "Hu",
"doi-asserted-by": "publisher",
"first-page": "6523",
"journal-title": "Med Sci Monit",
"key": "ref32",
"volume": "25",
"year": "2019"
},
{
"DOI": "10.1038/srep25754",
"author": "Li",
"doi-asserted-by": "publisher",
"first-page": "25754",
"journal-title": "Sci Rep",
"key": "ref33",
"volume": "6",
"year": "2016"
},
{
"DOI": "10.1016/j.virusres.2017.04.008",
"author": "Wang",
"doi-asserted-by": "publisher",
"first-page": "58",
"journal-title": "Virus Res",
"key": "ref34",
"volume": "235",
"year": "2017"
},
{
"DOI": "10.7196/SAMJ.2020.v111i11.15433",
"author": "Mendelson",
"doi-asserted-by": "publisher",
"first-page": "10",
"journal-title": "S Afr Med J",
"key": "ref35",
"volume": "111",
"year": "2020"
},
{
"DOI": "10.1016/j.amepre.2015.07.019",
"author": "Ali",
"doi-asserted-by": "publisher",
"first-page": "S230",
"journal-title": "Am J Prev Med",
"key": "ref36",
"volume": "49",
"year": "2015"
},
{
"DOI": "10.1371/journal.pone.0100903",
"author": "Morgan",
"doi-asserted-by": "publisher",
"first-page": "e100903",
"journal-title": "PLoS One",
"key": "ref37",
"volume": "9",
"year": "2014"
},
{
"DOI": "10.1016/S2213-8587(21)00051-6",
"author": "Jolliffe",
"doi-asserted-by": "publisher",
"first-page": "276",
"journal-title": "Lancet Diabetes Endocrinol",
"key": "ref38",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1016/j.lfs.2020.117583",
"author": "Zhang",
"doi-asserted-by": "publisher",
"first-page": "117583",
"journal-title": "Life Sci",
"key": "ref39",
"volume": "250",
"year": "2020"
},
{
"DOI": "10.1136/annrheumdis-2013-204378",
"author": "Zerr",
"doi-asserted-by": "publisher",
"first-page": "e20",
"journal-title": "Ann Rheum Dis",
"key": "ref40",
"volume": "74",
"year": "2015"
},
{
"DOI": "10.1016/j.ejim.2011.09.017",
"author": "Isik",
"doi-asserted-by": "publisher",
"first-page": "93",
"journal-title": "Eur J Intern Med",
"key": "ref41",
"volume": "23",
"year": "2012"
},
{
"DOI": "10.4269/ajtmh.20-0820",
"author": "Kapepula",
"doi-asserted-by": "publisher",
"first-page": "960",
"journal-title": "Am J Trop Med Hyg",
"key": "ref42",
"volume": "103",
"year": "2020"
},
{
"DOI": "10.3389/fphar.2021.649532",
"author": "Uckun",
"doi-asserted-by": "publisher",
"first-page": "649532",
"journal-title": "Front Pharmacol",
"key": "ref43",
"volume": "12",
"year": "2021"
},
{
"DOI": "10.1016/j.jsbmb.2020.105751",
"author": "Entrenas Castillo",
"doi-asserted-by": "publisher",
"first-page": "105751",
"journal-title": "J Steroid Biochem Mol Biol",
"key": "ref44",
"volume": "203",
"year": "2020"
},
{
"DOI": "10.3390/nu12123799",
"author": "Ling",
"doi-asserted-by": "publisher",
"first-page": "12",
"journal-title": "Nutrients",
"key": "ref45",
"volume": "12",
"year": "2020"
},
{
"DOI": "10.3390/nu12040988",
"author": "Grant",
"doi-asserted-by": "publisher",
"journal-title": "Nutrients",
"key": "ref46",
"volume": "12",
"year": "2020"
},
{
"DOI": "10.7150/ijms.48053",
"author": "Feitosa",
"doi-asserted-by": "publisher",
"first-page": "2133",
"journal-title": "Int J Med Sci",
"key": "ref47",
"volume": "17",
"year": "2020"
},
{
"DOI": "10.3389/fnhum.2017.00315",
"author": "Cahn",
"doi-asserted-by": "publisher",
"first-page": "315",
"journal-title": "Front Hum Neurosci",
"key": "ref48",
"volume": "11",
"year": "2017"
},
{
"DOI": "10.1111/j.1749-6632.2009.04959.x",
"author": "Bushell",
"doi-asserted-by": "publisher",
"first-page": "5",
"journal-title": "Ann N Y Acad Sci",
"key": "ref49",
"volume": "1172",
"year": "2009"
},
{
"DOI": "10.1016/S0140-6736(20)31022-9",
"author": "Wang",
"doi-asserted-by": "publisher",
"first-page": "1569",
"journal-title": "Lancet",
"key": "ref50",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1080/21645515.2017.1316909",
"author": "Sheppard",
"doi-asserted-by": "publisher",
"first-page": "1972",
"journal-title": "Hum Vaccin Immunother",
"key": "ref51",
"volume": "13",
"year": "2017"
},
{
"DOI": "10.1089/acm.2020.0177",
"author": "Bushell",
"doi-asserted-by": "publisher",
"first-page": "547",
"journal-title": "J Altern Complement Med",
"key": "ref52",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1016/j.ekir.2020.12.003",
"author": "Aiswarya",
"doi-asserted-by": "publisher",
"first-page": "586",
"journal-title": "Kidney Int Rep",
"key": "ref53",
"volume": "6",
"year": "2021"
},
{
"DOI": "10.1016/j.lfs.2020.118167",
"author": "Akbari",
"doi-asserted-by": "publisher",
"first-page": "118167",
"journal-title": "Life Sci",
"key": "ref54",
"volume": "258",
"year": "2020"
},
{
"DOI": "10.1055/s-0034-1384587",
"author": "Alamdari",
"doi-asserted-by": "publisher",
"first-page": "504",
"journal-title": "Horm Metab Res",
"key": "ref55",
"volume": "47",
"year": "2015"
},
{
"DOI": "10.1007/s10787-012-0168-y",
"author": "Bartels",
"doi-asserted-by": "publisher",
"first-page": "177",
"journal-title": "Inflammopharmacology",
"key": "ref56",
"volume": "21",
"year": "2013"
},
{
"DOI": "10.1002/cncr.29194",
"author": "Bower",
"doi-asserted-by": "publisher",
"first-page": "1231",
"journal-title": "Cancer",
"key": "ref57",
"volume": "121",
"year": "2015"
},
{
"DOI": "10.1097/01.psy.0000074003.35911.41",
"author": "Carlson",
"doi-asserted-by": "publisher",
"first-page": "571",
"journal-title": "Psychosom Med",
"key": "ref58",
"volume": "65",
"year": "2003"
},
{
"DOI": "10.1016/s0306-4530(03)00054-4",
"author": "Carlson",
"doi-asserted-by": "publisher",
"first-page": "448",
"journal-title": "Psychoneuroendocrinology",
"key": "ref59",
"volume": "29",
"year": "2004"
},
{
"DOI": "10.1016/j.bbi.2007.04.002",
"author": "Carlson",
"doi-asserted-by": "publisher",
"first-page": "1038",
"journal-title": "Brain Behav Immun",
"key": "ref60",
"volume": "21",
"year": "2007"
},
{
"author": "Celinski",
"first-page": "75",
"journal-title": "J Physiol Pharmacol",
"key": "ref61",
"volume": "65",
"year": "2014"
},
{
"DOI": "10.1172/JCI137244",
"author": "Chen",
"doi-asserted-by": "publisher",
"first-page": "2620",
"journal-title": "J Clin Invest",
"key": "ref62",
"volume": "130",
"year": "2020"
},
{
"DOI": "10.3760/cma.j.issn.1001-0939.2020.0005",
"author": "Chen",
"doi-asserted-by": "publisher",
"first-page": "E005",
"journal-title": "Zhonghua Jie He He Hu Xi Za Zhi",
"key": "ref63",
"volume": "43",
"year": "2020"
},
{
"author": "Cichoz-Lach",
"first-page": "577",
"journal-title": "J Physiol Pharmacol",
"key": "ref64",
"volume": "61",
"year": "2010"
},
{
"DOI": "10.1038/tp.2016.164",
"author": "Epel",
"doi-asserted-by": "publisher",
"first-page": "e880",
"journal-title": "Transl Psychiatry",
"key": "ref65",
"volume": "6",
"year": "2016"
},
{
"DOI": "10.1007/s10461-013-0612-z",
"author": "Gonzalez-Garcia",
"doi-asserted-by": "publisher",
"first-page": "676",
"journal-title": "AIDS Behav",
"key": "ref66",
"volume": "18",
"year": "2014"
},
{
"DOI": "10.4103/2277-9175.194801",
"author": "Javanmard",
"doi-asserted-by": "publisher",
"first-page": "174",
"journal-title": "Adv Biomed Res",
"key": "ref67",
"volume": "5",
"year": "2016"
},
{
"DOI": "10.1177/1099800411419245",
"author": "Lengacher",
"doi-asserted-by": "publisher",
"first-page": "37",
"journal-title": "Biol Res Nurs",
"key": "ref68",
"volume": "15",
"year": "2013"
},
{
"DOI": "10.1093/cid/ciaa248",
"author": "Qin",
"doi-asserted-by": "publisher",
"journal-title": "Clin Infect Dis",
"key": "ref69",
"year": "2020"
},
{
"DOI": "10.1159/000058001",
"author": "Rausch-Fan",
"doi-asserted-by": "publisher",
"first-page": "33",
"journal-title": "Int Arch Allergy Immunol",
"key": "ref70",
"volume": "128",
"year": "2002"
},
{
"DOI": "10.1016/j.clnu.2017.12.004",
"author": "Raygan",
"doi-asserted-by": "publisher",
"first-page": "191",
"journal-title": "Clin Nutr",
"key": "ref71",
"volume": "38",
"year": "2019"
},
{
"DOI": "10.1016/j.psyneuen.2016.02.013",
"author": "Rosenkranz",
"doi-asserted-by": "publisher",
"first-page": "117",
"journal-title": "Psychoneuroendocrinology",
"key": "ref72",
"volume": "68",
"year": "2016"
},
{
"DOI": "10.4103/jehp.jehp_65_17",
"author": "Shete",
"doi-asserted-by": "publisher",
"first-page": "76",
"journal-title": "J Educ Health Promot",
"key": "ref73",
"volume": "6",
"year": "2017"
},
{
"DOI": "10.1016/S0140-6736(08)60453-5",
"author": "Smolen",
"doi-asserted-by": "publisher",
"first-page": "987",
"journal-title": "Lancet",
"key": "ref74",
"volume": "371",
"year": "2008"
},
{
"DOI": "10.1093/infdis/jiaa150",
"author": "Wang",
"doi-asserted-by": "publisher",
"first-page": "1762",
"journal-title": "J Infect Dis",
"key": "ref75",
"volume": "221",
"year": "2020"
},
{
"DOI": "10.1016/j.bbi.2008.01.012",
"author": "Witek-Janusek",
"doi-asserted-by": "publisher",
"first-page": "969",
"journal-title": "Brain Behav Immun",
"key": "ref76",
"volume": "22",
"year": "2008"
},
{
"DOI": "10.1080/22221751.2020.1746200",
"author": "Meng",
"doi-asserted-by": "publisher",
"first-page": "757",
"journal-title": "Emerg Microbes Infect",
"key": "ref77",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.32598/bcn.11.covid19.1168.2",
"author": "Ramezani",
"doi-asserted-by": "publisher",
"first-page": "179",
"journal-title": "Basic Clin Neurosci",
"key": "ref78",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/j.cytox.2020.100029",
"author": "Magro",
"doi-asserted-by": "publisher",
"first-page": "100029",
"journal-title": "Cytokine X",
"key": "ref79",
"volume": "2",
"year": "2020"
},
{
"DOI": "10.1080/00031305.2016.1154108",
"author": "Wasserstein",
"doi-asserted-by": "publisher",
"first-page": "2129",
"journal-title": "Am Stat",
"key": "ref80",
"volume": "70",
"year": "2016"
},
{
"author": "Faraone",
"first-page": "700",
"journal-title": "P T",
"key": "ref81",
"volume": "33",
"year": "2008"
},
{
"DOI": "10.1016/j.intimp.2005.05.010",
"author": "Mihara",
"doi-asserted-by": "publisher",
"first-page": "1731",
"journal-title": "Int Immunopharmacol",
"key": "ref82",
"volume": "5",
"year": "2005"
},
{
"DOI": "10.3760/cma.j.cn121430-20200312-00412",
"author": "Lin",
"doi-asserted-by": "publisher",
"first-page": "417",
"journal-title": "Zhonghua Wei Zhong Bing Ji Jiu Yi Xue",
"key": "ref83",
"volume": "32",
"year": "2020"
}
],
"reference-count": 83,
"references-count": 83,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.dovepress.com/implications-for-systemic-approaches-to-covid-19-effect-sizes-of-remde-peer-reviewed-fulltext-article-JIR"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab, Melatonin, Vitamin D3, and Meditation",
"type": "journal-article",
"volume": "Volume 14"
}